cgs 10746b has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilsky, EJ; Montegut, MJ; Nichols, ML; Reid, LD | 1 |
| Aguilar, MA; Daza-Losada, M; Miñarro, J; Rodríguez-Arias, M; Roger-Sánchez, C; Vidal-Infer, A | 1 |
2 other study(ies) available for cgs 10746b and n-methyl-3,4-methylenedioxyamphetamine
| Article | Year |
|---|---|
CGS 10746B, a novel dopamine release inhibitor, blocks the establishment of cocaine and MDMA conditioned place preferences.
Topics: Analysis of Variance; Animals; Choice Behavior; Cocaine; Conditioning, Operant; Cues; Dopamine; Dopamine Agents; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Thiazepines | 1998 |
Role of the dopaminergic system in the acquisition, expression and reinstatement of MDMA-induced conditioned place preference in adolescent mice.
Topics: Animals; Benzazepines; Blotting, Western; Conditioning, Operant; Dopamine; Dopamine Antagonists; Haloperidol; Male; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Raclopride; Serotonin; Thiazepines | 2012 |